Blume Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8K Hold
100
﹤0.01% 245
2026
Q1
$21.1K Hold
100
﹤0.01% 245
2025
Q4
$20.6K Hold
100
﹤0.01% 233
2025
Q3
$15.7K Hold
100
﹤0.01% 257
2025
Q2
$16.8K Hold
100
﹤0.01% 249
2025
Q1
$13.8K Hold
100
﹤0.01% 254
2024
Q4
$11.8K Hold
100
﹤0.01% 250
2024
Q3
$11.1K Hold
100
﹤0.01% 267
2024
Q2
$9.83K Hold
100
﹤0.01% 251
2024
Q1
$11.2K Hold
100
﹤0.01% 241
2023
Q4
$10.1K Hold
100
﹤0.01% 243
2023
Q3
$8.68K Hold
100
﹤0.01% 247
2023
Q2
$9.46K Hold
100
﹤0.01% 248
2023
Q1
$7.55K Sell
100
-24
-19% -$1.81K ﹤0.01% 258
2022
Q4
$9.53K Hold
124
﹤0.01% 250
2022
Q3
$8K Buy
+124
New +$7.86K ﹤0.01% 248

Other funds holding CAH

Blume Capital Management's CAH Position: Q2 2026 in Review

Blume Capital Management held its Cardinal Health (CAH) position steady in Q2 2026 at 100 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #245.

Blume Capital Management first reported a position in CAH in Q3 2022 and has held it in 16 quarters since. 797 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Blume Capital Management held 100 shares of Cardinal Health worth $23.8K as of Q2 2026.
  • Blume Capital Management left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Blume Capital Management's portfolio in Q2 2026, its #245 holding.
  • Blume Capital Management first reported a position in Cardinal Health in Q3 2022 and has held it in 16 quarters since.
  • 797 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.